Unknown

Dataset Information

0

Enrofloxacin Alters Fecal Microbiota and Resistome Irrespective of Its Dose in Calves.


ABSTRACT: Enrofloxacin is a fluoroquinolone drug used to prevent and control bovine respiratory disease (BRD) complex in multiple or single doses, ranging from 7.5 to 12.5 mg/kg body weight. Here, we examined the effects of high and low doses of a single subcutaneously injected enrofloxacin on gut microbiota and resistome in calves. Thirty-five calves sourced for this study were divided into five groups: control (n = 7), two low dose groups (n = 14, 7.5 mg/kg), and two high dose groups (n = 14, 12.5 mg/kg). One group in the low and high dose groups was challenged with Mannheimia haemolytica to induce BRD. Both alpha and beta diversities were significantly different between pre- and post-treatment microbial communities (q < 0.05). The high dose caused a shift in a larger number of genera than the low dose. Using metagenomic ProxiMeta Hi-C, 32 unique antimicrobial resistance genes (ARGs) conferring resistance to six antibiotic classes were detected with their reservoirs, and the high dose favored clonal expansion of ARG-carrying bacterial hosts. In conclusion, enrofloxacin treatment can alter fecal microbiota and resistome irrespective of its dose. Hi-C sequencing provides significant benefits for unlocking new insights into the ARG ecology of complex samples; however, limitations in sample size and sequencing depth suggest that further work is required to validate the findings.

SUBMITTER: Beyi AF 

PROVIDER: S-EPMC8537546 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enrofloxacin Alters Fecal Microbiota and Resistome Irrespective of Its Dose in Calves.

Beyi Ashenafi Feyisa AF   Brito-Goulart Debora D   Hawbecker Tyler T   Ruddell Brandon B   Hassall Alan A   Dewell Renee R   Dewell Grant G   Sahin Orhan O   Zhang Qijing Q   Plummer Paul J PJ  

Microorganisms 20211017 10


Enrofloxacin is a fluoroquinolone drug used to prevent and control bovine respiratory disease (BRD) complex in multiple or single doses, ranging from 7.5 to 12.5 mg/kg body weight. Here, we examined the effects of high and low doses of a single subcutaneously injected enrofloxacin on gut microbiota and resistome in calves. Thirty-five calves sourced for this study were divided into five groups: control (<i>n</i> = 7), two low dose groups (<i>n</i> = 14, 7.5 mg/kg), and two high dose groups (<i>n  ...[more]

Similar Datasets

| S-EPMC8538188 | biostudies-literature
| S-EPMC6905572 | biostudies-literature
| S-EPMC9386515 | biostudies-literature
| S-EPMC9064827 | biostudies-literature
2025-04-30 | GSE271297 | GEO
| S-EPMC6761860 | biostudies-literature
| S-EPMC10039250 | biostudies-literature
| S-EPMC4233928 | biostudies-literature
| S-EPMC9598087 | biostudies-literature
| S-EPMC11264934 | biostudies-literature